- Haemolysed sample identification in BA/BE study and others vish14184 2018-05-09 17:43
- Haemolysed sample identification in BA/BE study and others Ohlbe 2018-05-14 10:38
- oral powder with water acceptable? chris089 2018-04-16 13:43
- oral powder with water acceptable? ElMaestro 2018-04-16 14:14
- oral powder with water acceptable? chris089 2018-04-17 12:12
- oral powder with water acceptable? ElMaestro 2018-04-17 12:57
- oral powder with water acceptable? chris089 2018-04-17 15:57
- oral powder with water acceptable? ElMaestro 2018-04-17 16:23
- oral powder with water acceptable? chris089 2018-04-19 16:18
- oral powder with water acceptable? ElMaestro 2018-04-19 18:30
- oral powder with water acceptable? chris089 2018-04-19 18:36
- oral powder with water acceptable? ElMaestro 2018-04-19 18:30
- oral powder with water acceptable? chris089 2018-04-19 16:18
- oral powder with water acceptable? ElMaestro 2018-04-17 16:23
- oral powder with water acceptable? chris089 2018-04-17 15:57
- oral powder with water acceptable? ElMaestro 2018-04-17 12:57
- oral powder with water acceptable? chris089 2018-04-17 12:12
- oral powder with water acceptable? ElMaestro 2018-04-16 14:14
- Biowaiver of Product with TE code AA rajibkumar 2018-04-18 07:37
- bioequivalence of drug combination Norah 2018-04-02 12:29
- bioequivalence of drug combination Beholder 2018-04-09 09:04
- bioequivalence of drug combination Norah 2018-04-10 15:26
- bioequivalence of drug combination balakotu 2018-04-13 06:40
- bioequivalence of drug combination Beholder 2018-04-09 09:04
- Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-09 05:54
- Primidone BE study for USFDA submission jag009 2018-04-09 16:16
- Primidone BE study for USFDA submission bebac_fan 2018-04-10 01:11
- Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-11 06:07
- Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-11 06:05
- Primidone BE study for USFDA submission bebac_fan 2018-04-10 01:11
- Primidone BE study for USFDA submission balakotu 2018-04-12 15:01
- Primidone BE study for USFDA submission jag009 2018-04-09 16:16
- In vitro Bioequivalence for suspension ophthalmic Weidson 2018-04-09 20:40
- Inclusion criteria (ANVISA) maverick 2009-10-13 10:48
- Inclusion criteria (ANVISA) Helmut 2009-10-13 12:32
- Inclusion criteria (ANVISA) patel_prakash79 2009-12-03 11:07
- RDC No 34 (2008) Helmut 2009-12-04 02:38
- RDC No 34 (2008) Jaime_R 2009-12-07 02:09
- RDC No 34 (2008) Helmut 2009-12-08 14:15
- RDC No 34 (2008) Karupu 2010-10-04 08:29
- ANVISA’s site Helmut 2010-10-04 14:35
- ANVISA’s site Karupu 2010-10-04 15:25
- ANVISA's site Helmut 2010-10-04 15:33
- ANVISA’s site Karupu 2010-10-04 15:58
- ANVISA's site Helmut 2010-10-04 15:33
- ANVISA’s site Karupu 2010-10-04 15:25
- ANVISA’s site Helmut 2010-10-04 14:35
- RDC No 34 (2008) Jaime_R 2009-12-07 02:09
- RDC No 34 (2008) Helmut 2009-12-04 02:38
- Inclusion criteria (ANVISA) patel_prakash79 2009-12-03 11:07
- Inclusion criteria (ANVISA) kartikpharma 2009-12-03 09:40
- Inclusion criteria (ANVISA) BRB 2018-04-05 00:18
- Inclusion criteria (ANVISA) Helmut 2009-10-13 12:32
- FDA-Subject by formulation interaction (Switchability) sudy 2018-03-28 07:09
- Risking Refuse-to-Receive Helmut 2018-03-28 11:25
- Risking Refuse-to-Receive sudy 2018-03-28 12:13
- Risking Refuse-to-Receive jag009 2018-03-28 21:35
- FDA-Subject by formulation interaction (Switchability) jag009 2018-03-28 21:33
- Risking Refuse-to-Receive Helmut 2018-03-28 11:25
- Different sources of Prescribing Information Siddheshwar Shinde 2018-03-21 11:07
- Different sources of Prescribing Information Ohlbe 2018-03-21 18:14
- Different sources of Prescribing Information Siddheshwar Shinde 2018-03-23 05:23
- Different sources of Prescribing Information jag009 2018-03-22 19:11
- Different sources of Prescribing Information Ohlbe 2018-03-21 18:14
- Profile comparison requirements PriyalAayushi 2018-03-13 04:09
- Homework Helmut 2018-03-13 13:36
- Profile comparison requirements jag009 2018-03-15 21:45
- BE waiver for proportional formula Luongnv 2018-02-22 07:35
- BE waiver for proportional formula m.ross 2018-03-15 12:11
- fed or fasting conditions studies Norah 2018-03-14 11:57
- specific guidelines for psychotropic Norah 2018-03-09 16:48
- specific guidelines for psychotropic Helmut 2018-03-09 17:44
- specific guidelines for psychotropic nobody 2018-03-09 18:13
- specific guidelines for psychotropic Norah 2018-03-12 09:37
- specific guidelines for psychotropic Norah 2018-03-12 09:37
- specific guidelines for psychotropic nobody 2018-03-09 18:13
- specific guidelines for psychotropic mittyri 2018-03-10 08:38
- specific guidelines for psychotropic Norah 2018-03-12 09:38
- specific guidelines for psychotropic Helmut 2018-03-09 17:44
- IP retention EU regulatory requirements manusyriac 2018-03-08 10:20
- Sampling Time points and Sample Size Sai 2018-02-22 03:11
- Sampling Time points and Sample Size jag009 2018-02-23 18:06
- Sampling Time points and Sample Size Sai 2018-02-23 19:40
- Sampling Time points and Sample Size Maitri 2018-03-04 10:59
- Sampling Time points and Sample Size Sai 2018-02-23 19:40
- Sampling Time points and Sample Size jag009 2018-02-23 18:06
